Literature DB >> 15320994

HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania.

Miguel A Arroyo1, Michael Hoelscher, Eric Sanders-Buell, Karl-Heinz Herbinger, Eleuter Samky, Leonard Maboko, Oliver Hoffmann, Merlin R Robb, Deborah L Birx, Francine E McCutchan.   

Abstract

HIV-1 is endemic in Tanzania where three different subtypes, A, C, and D, have been identified. Information on HIV-1 genetic diversity is crucial to define requirements for an effective vaccine, in regions where HIV-1 vaccine trials are planned. To define the subtype distribution of HIV-1 in the Mbeya region of southwest Tanzania, peripheral blood mononuclear cells (PBMC) and plasma were obtained from 36 discarded HIV seropositive blood units. Multiregion hybridization assay (MHA) was performed on both PBMC DNA and plasma RNA to determine the subtype distribution. Twenty virtually full-length HIV-1 sequences were amplified from the extracted DNA, sequenced, and phylogenetically analyzed. Subtype distribution determined by all three assays was comparable. More than 50% of the samples analyzed were subtype C, followed by a high proportion of subtype C-containing intersubtype recombinants. Based on this work, subtype C appears to be the prevalent subtype in southwest Tanzania, followed by a high proportion of intersubtype recombinants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320994     DOI: 10.1089/0889222041725235

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  23 in total

1.  Development of an AIDS vaccine: a daunting epidemiological challenge.

Authors:  Neal Nathanson; Bonnie J Mathieson
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Prevalence of drug resistance mutations and HIV type 1 subtypes in an HIV type 1-infected cohort in rural Tanzania.

Authors:  Pax Masimba; Elimsaada Kituma; Thomas Klimkait; Edit Horvath; Marcel Stoeckle; Christoph Hatz; Erick Mossdorf; Emmanuel Mwaigomole; Salim Khamis; Boniphace Jullu; Salim Abdulla; Marcel Tanner; Ingrid Felger
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09       Impact factor: 2.205

3.  In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection.

Authors:  F E McCutchan; M Hoelscher; S Tovanabutra; S Piyasirisilp; E Sanders-Buell; G Ramos; L Jagodzinski; V Polonis; L Maboko; D Mmbando; O Hoffmann; G Riedner; F von Sonnenburg; M Robb; D L Birx
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.

Authors:  Muhammad Bakari; Said Aboud; Charlotta Nilsson; Joel Francis; Deus Buma; Candida Moshiro; Eric A Aris; Eligius F Lyamuya; Mohamed Janabi; Karina Godoy-Ramirez; Agricola Joachim; Victoria R Polonis; Andreas Bråve; Patricia Earl; Merlin Robb; Mary Marovich; Britta Wahren; Kisali Pallangyo; Gunnel Biberfeld; Fred Mhalu; Eric Sandström
Journal:  Vaccine       Date:  2011-08-22       Impact factor: 3.641

5.  Novel multiregion hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 circulating in Portugal.

Authors:  Ferdinando B Freitas; Aida Esteves; João Piedade; Ricardo Parreira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-25       Impact factor: 2.205

6.  Elevated hypermutation levels in HIV-1 natural viral suppressors.

Authors:  Lindsay M Eyzaguirre; Manhattan Charurat; Robert R Redfield; William A Blattner; Jean K Carr; Mohammad M Sajadi
Journal:  Virology       Date:  2013-06-19       Impact factor: 3.616

7.  HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.

Authors:  Noah Kiwanuka; Merlin Robb; Oliver Laeyendecker; Godfrey Kigozi; Fred Wabwire-Mangen; Fredrick E Makumbi; Fred Nalugoda; Joseph Kagaayi; Michael Eller; Leigh Anne Eller; David Serwadda; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Ronald H Gray; Maria J Wawer; Christopher C Whalen
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

8.  HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda.

Authors:  Noah Kiwanuka; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer; James Shepherd; Merlin Robb; Godfrey Kigozi; Joseph Kagaayi; David Serwadda; Fred E Makumbi; Steven J Reynolds; Ronald H Gray
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

9.  Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.

Authors:  Patricia L Earl; Catherine Cotter; Bernard Moss; Thomas VanCott; Jeffrey Currier; Leigh Anne Eller; Francine McCutchan; Deborah L Birx; Nelson L Michael; Mary A Marovich; Merlin Robb; Josephine H Cox
Journal:  Vaccine       Date:  2009-08-03       Impact factor: 3.641

10.  Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, Uganda.

Authors:  David Guwatudde; Fred Wabwire-Mangen; Leigh Anne Eller; Michael Eller; Francine McCutchan; Hannah Kibuuka; Monica Millard; Nelson Sewankambo; David Serwadda; Nelson Michael; Merlin Robb
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.